Maze Therapeutics Stock Forward View - Simple Moving Average
| MAZE Stock | 45.03 1.08 2.46% |
Maze Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Maze Therapeutics stock prices and determine the direction of Maze Therapeutics Common's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Maze Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of Maze Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Current Year (3.07) | EPS Estimate Next Year (3.15) | Wall Street Target Price 49.4444 |
Using Maze Therapeutics hype-based prediction, you can estimate the value of Maze Therapeutics Common from the perspective of Maze Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Maze Therapeutics using Maze Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Maze using crowd psychology based on the activity and movement of Maze Therapeutics' stock price.
Maze Therapeutics Implied Volatility | 1.33 |
Maze Therapeutics' implied volatility exposes the market's sentiment of Maze Therapeutics Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Maze Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Maze Therapeutics stock will not fluctuate a lot when Maze Therapeutics' options are near their expiration.
The Simple Moving Average forecasted value of Maze Therapeutics Common on the next trading day is expected to be 45.03 with a mean absolute deviation of 1.16 and the sum of the absolute errors of 69.70. Maze Therapeutics after-hype prediction price | USD 46.47 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Maze Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Maze contract
Based on the Rule 16, the options market is currently suggesting that Maze Therapeutics Common will have an average daily up or down price movement of about 0.0831% per day over the life of the 2026-05-15 option contract. With Maze Therapeutics trading at USD 45.03, that is roughly USD 0.0374 . If you think that the market is fully incorporating Maze Therapeutics' daily price movement you should consider acquiring Maze Therapeutics Common options at the current volatility level of 1.33%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 Maze Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Maze Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Maze Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Maze Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Maze Therapeutics' open interest, investors have to compare it to Maze Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Maze Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Maze. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Maze Therapeutics Additional Predictive Modules
Most predictive techniques to examine Maze price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Maze using various technical indicators. When you analyze Maze charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Maze Therapeutics Simple Moving Average Price Forecast For the 8th of February
Given 90 days horizon, the Simple Moving Average forecasted value of Maze Therapeutics Common on the next trading day is expected to be 45.03 with a mean absolute deviation of 1.16, mean absolute percentage error of 2.29, and the sum of the absolute errors of 69.70.Please note that although there have been many attempts to predict Maze Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Maze Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Maze Therapeutics Stock Forecast Pattern
| Backtest Maze Therapeutics | Maze Therapeutics Price Prediction | Research Analysis |
Maze Therapeutics Forecasted Value
In the context of forecasting Maze Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Maze Therapeutics' downside and upside margins for the forecasting period are 41.41 and 48.65, respectively. We have considered Maze Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Maze Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Maze Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.1019 |
| Bias | Arithmetic mean of the errors | -0.334 |
| MAD | Mean absolute deviation | 1.1617 |
| MAPE | Mean absolute percentage error | 0.0283 |
| SAE | Sum of the absolute errors | 69.7 |
Predictive Modules for Maze Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Maze Therapeutics Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Maze Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Maze Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Maze Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Maze Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Maze Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Maze Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Maze Therapeutics' historical news coverage. Maze Therapeutics' after-hype downside and upside margins for the prediction period are 42.85 and 50.09, respectively. We have considered Maze Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Maze Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Maze Therapeutics Common is based on 3 months time horizon.
Maze Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Maze Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Maze Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Maze Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.70 | 3.62 | 1.44 | 0.96 | 7 Events / Month | 7 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
45.03 | 46.47 | 3.20 |
|
Maze Therapeutics Hype Timeline
Maze Therapeutics Common is now traded for 45.03. The entity has historical hype elasticity of 1.44, and average elasticity to hype of competition of 0.96. Maze is forecasted to increase in value after the next headline, with the price projected to jump to 46.47 or above. The average volatility of media hype impact on the company the price is about 175.73%. The price growth on the next news is projected to be 3.2%, whereas the daily expected return is now at 0.7%. The volatility of related hype on Maze Therapeutics is about 263.08%, with the expected price after the next announcement by competition of 45.99. Maze Therapeutics Common currently holds 26.63 M in liabilities. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out Historical Fundamental Analysis of Maze Therapeutics to cross-verify your projections.Maze Therapeutics Related Hype Analysis
Having access to credible news sources related to Maze Therapeutics' direct competition is more important than ever and may enhance your ability to predict Maze Therapeutics' future price movements. Getting to know how Maze Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Maze Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| COR | Cencora | (3.67) | 9 per month | 2.25 | 0.01 | 2.01 | (2.45) | 11.54 | |
| REGN | Regeneron Pharmaceuticals | 1.69 | 3 per month | 1.40 | 0.12 | 3.40 | (2.61) | 8.86 | |
| IDXX | IDEXX Laboratories | (2.33) | 9 per month | 0.00 | (0.15) | 3.61 | (3.03) | 9.91 | |
| HLN | Haleon plc | (0.01) | 8 per month | 0.96 | 0.12 | 2.81 | (1.81) | 6.06 | |
| CI | Cigna Corp | 3.48 | 11 per month | 1.14 | 0.07 | 3.20 | (2.06) | 7.49 | |
| ELV | Elevance Health | 1.69 | 4 per month | 2.90 | 0.03 | 3.78 | (2.51) | 19.95 | |
| BDX | Becton Dickinson and | 0.69 | 10 per month | 0.69 | 0.13 | 2.93 | (1.77) | 7.14 | |
| ELAN | Elanco Animal Health | (0.51) | 10 per month | 1.85 | 0.04 | 3.66 | (4.00) | 10.56 | |
| ARGX | argenx NV ADR | 12.71 | 8 per month | 0.00 | (0.07) | 2.29 | (3.07) | 7.34 | |
| TAK | Takeda Pharmaceutical Co | 0.02 | 9 per month | 0.00 | 0.32 | 2.49 | (1.05) | 4.49 |
Other Forecasting Options for Maze Therapeutics
For every potential investor in Maze, whether a beginner or expert, Maze Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Maze Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Maze. Basic forecasting techniques help filter out the noise by identifying Maze Therapeutics' price trends.Maze Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maze Therapeutics stock to make a market-neutral strategy. Peer analysis of Maze Therapeutics could also be used in its relative valuation, which is a method of valuing Maze Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Maze Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Maze Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Maze Therapeutics shares will generate the highest return on investment. By undertsting and applying Maze Therapeutics stock market strength indicators, traders can identify Maze Therapeutics Common entry and exit signals to maximize returns.
| Accumulation Distribution | 48703.83 | |||
| Daily Balance Of Power | 0.3186 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 44.49 | |||
| Day Typical Price | 44.67 | |||
| Price Action Indicator | 1.09 | |||
| Period Momentum Indicator | 1.08 |
Maze Therapeutics Risk Indicators
The analysis of Maze Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Maze Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting maze stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.92 | |||
| Semi Deviation | 2.99 | |||
| Standard Deviation | 3.74 | |||
| Variance | 13.97 | |||
| Downside Variance | 11.14 | |||
| Semi Variance | 8.96 | |||
| Expected Short fall | (3.24) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Maze Therapeutics
The number of cover stories for Maze Therapeutics depends on current market conditions and Maze Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Maze Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Maze Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Maze Therapeutics Short Properties
Maze Therapeutics' future price predictability will typically decrease when Maze Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Maze Therapeutics Common often depends not only on the future outlook of the potential Maze Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Maze Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 43.8 M | |
| Cash And Short Term Investments | 196.8 M |
Check out Historical Fundamental Analysis of Maze Therapeutics to cross-verify your projections. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Will Pharmaceuticals sector continue expanding? Could Maze diversify its offerings? Factors like these will boost the valuation of Maze Therapeutics. Expected growth trajectory for Maze significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Maze Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Maze Therapeutics Common is measured differently than its book value, which is the value of Maze that is recorded on the company's balance sheet. Investors also form their own opinion of Maze Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Maze Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Maze Therapeutics' market value can be influenced by many factors that don't directly affect Maze Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Maze Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Maze Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Maze Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.